This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter    Login        

Oncology

18
Zoledronic acid improves disease-free survival in pre-menopausal HR+ early breast cancer
Zoledronic acid improves disease-free survival in pre-menopausal HR+ early breast cancer
Read more
Drugs for treating breast cancer in women are effective and well tolerated in men
Drugs for treating breast cancer in women are effective and well tolerated in men
Read more
Lilly receives EU marketing authorisation for abemaciclib in metastatic breast cancer
Lilly receives EU marketing authorisation for abemaciclib in metastatic breast cancer
Read more
Oral anticoagulants and cancer-associated thrombosis
Read more
CAR T-cell therapy: managing side effects
Read more
Perspectives for treating cancer-associated thrombosis
Read more
Implications of licensed standardised chemotherapy doses and their potential impact
Read more
Anti-GD2 mAbs for the treatment of high-risk neuroblastoma
Read more
The new kid on the block
Read more
Predictive biomarker analysis in NSCLC
Read more
European Commission approves BRAFTOVI and MEKTOVI to treat advanced BRAF-mutant melanoma
European Commission approves BRAFTOVI and MEKTOVI to treat advanced BRAF-mutant melanoma
Read more
NGS is helping oncologists make informed treatment decisions
NGS is helping oncologists make informed treatment decisions
Read more
Novartis UK oncology comments on European Commission approval of CART-T therapy Kymriah
Novartis UK oncology comments on European Commission approval of CART-T therapy Kymriah
Read more
European Commission approves Vyxeos to treat certain types of high-risk acute myeloid leukaemia
European Commission approves Vyxeos to treat certain types of high-risk acute myeloid leukaemia
Read more
New patient groups with cancer-associated VTE could be treated with once-daily oral LIXIANA, analysis shows
New patient groups with cancer-associated VTE could be treated with once-daily oral LIXIANA, analysis shows
Read more
Why I love being an oncology pharmacist
Why I love being an oncology pharmacist
Read more
CHMP gives positive opinion on using tisagenlecleucel to treat two aggressive blood cancers
CHMP gives positive opinion on using tisagenlecleucel to treat two aggressive blood cancers
Read more
Drug trial to investigate anti-tumour effect on patients with metastatic breast cancer
Drug trial to investigate anti-tumour effect on patients with metastatic breast cancer
Read more

Popular articles

Can plastic waste really be turned into sustainable paracetamol?
New NHS operating model and financial incentives explained
Cardiology, respiratory and dermatology to be prioritised in NHS technology expansion
New DNA repair deficiency syndrome highlights need to tailor chemo regimens
Personalised care plans for majority of complex patients within two years, says Government



 
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2025
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x